• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

热休克蛋白70(Hsp70)联合白细胞介素-15(IL-15)和程序性死亡受体1(PD-1)阻断剂可干扰复发急性髓系白血病患者中细胞毒性自然杀伤细胞的诱导。

Hsp70, in Combination with IL-15 and PD-1 Blocker, Interferes with The Induction of Cytotoxic NK Cells in Relapsed Acute Myeloid Leukemia Patients.

作者信息

Firouzi Javad, Hajifathali Abbas, Azimi Masoumeh, Parvini Neda, Ghaemi Fatemeh, Shayan Asl Niloufar, Hedayati Asl Amir Abbas, Safa Majid, Ebrahimi Marzieh

机构信息

Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.

Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

出版信息

Cell J. 2023 Feb 1;25(2):92-101. doi: 10.22074/cellj.2023.561054.1123.

DOI:10.22074/cellj.2023.561054.1123
PMID:36840455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9968373/
Abstract

OBJECTIVE

Natural killer (NK) cells are critical immune cells for acute myeloid leukemia (AML) targeting. However, little is known about the relationship between using checkpoint inhibitors and heat shock protein 70 (Hsp70) as NK cell activators to control AML. Therefore, the study aims to find the best formulation of Hsp70, human PD-1 (Programmed cell death protein 1) blocker, and interleukin 15 (IL-15) to activate NK cells against AML.

MATERIALS AND METHODS

In this experimental study, the NK cells were isolated from mononuclear cells (MNCs) by using magnetic activation cell sorting (MACS) and were activated using the different combinations of Hsp70, PD-1 blocker, and IL-15 and then followed by immunophenotyping, functional assays to estimate their killing potential, and evaluation of expression pattern of and A and B.

RESULTS

The expression of PD-1 was significantly (P<0.05) reduced after NK cell activation by the different formulas of IL-15, Hsp70, and PD-1 blocker. The expression of NKG2A in the treated NK cells was reduced particularly in the IL-15 (P<0.01) and IL-15+PD-1 blocker (P<0.05) groups. The addition of Hsp70 increased its expression. The cytotoxic effect of NK cells increased in all groups, especially in IL-15+PD-1 blocker besides increasing interferon-gamma (IFN-γ), Granzymes, and perforin expression (P<0.05). All IL-15+PD-1 blocker group changes were associated with the upregulation of and as key factors of NK cell activation. The presence of Hsp70 reduced IFN-γ releasing, and down-regulation of Granzymes, and Perforin (P<0.05).

CONCLUSION

We suggested the combination of IL-15 and PD-1 blocker could enhance the killing potential of AMLNK cells. Moreover, Hsp70 in combination with IL-15 and PD-1 blocker interferes activation of AML-NK cells through unknown mechanisms.

摘要

目的

自然杀伤(NK)细胞是靶向急性髓系白血病(AML)的关键免疫细胞。然而,关于使用检查点抑制剂和热休克蛋白70(Hsp70)作为NK细胞激活剂来控制AML之间的关系,我们了解甚少。因此,本研究旨在寻找Hsp70、人程序性死亡蛋白1(PD - 1)阻断剂和白细胞介素15(IL - 15)激活NK细胞对抗AML的最佳配方。

材料与方法

在本实验研究中,通过磁激活细胞分选(MACS)从单核细胞(MNCs)中分离出NK细胞,并使用Hsp70、PD - 1阻断剂和IL - 15的不同组合对其进行激活,随后进行免疫表型分析、功能测定以评估其杀伤潜力,并评估 和 A和B的表达模式。

结果

通过IL - 15、Hsp70和PD - 1阻断剂的不同配方激活NK细胞后,PD - 1的表达显著降低(P < 0.05)。在经处理的NK细胞中,NKG2A的表达降低,特别是在IL - 15组(P < 0.01)和IL - 15 + PD - 1阻断剂组(P < 0.05)。添加Hsp70可增加其表达。所有组中NK细胞的细胞毒性作用均增强,特别是在IL - 15 + PD - 1阻断剂组,同时干扰素 - γ(IFN - γ)、颗粒酶和穿孔素的表达也增加(P < 0.05)。IL - 15 + PD - 1阻断剂组的所有变化均与作为NK细胞激活关键因子的 和 的上调有关。Hsp70的存在降低了IFN - γ的释放,并下调了颗粒酶和穿孔素(P < 0.05)。

结论

我们认为IL - 15和PD - 1阻断剂的组合可增强AML - NK细胞的杀伤潜力。此外,Hsp70与IL - 15和PD - 1阻断剂联合使用会通过未知机制干扰AML - NK细胞的激活。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3147/9968373/c8ab9f4bd237/Cell-J-25-92-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3147/9968373/34b1ac162b98/Cell-J-25-92-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3147/9968373/b08a16558d93/Cell-J-25-92-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3147/9968373/1484d13e5bfc/Cell-J-25-92-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3147/9968373/c8ab9f4bd237/Cell-J-25-92-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3147/9968373/34b1ac162b98/Cell-J-25-92-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3147/9968373/b08a16558d93/Cell-J-25-92-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3147/9968373/1484d13e5bfc/Cell-J-25-92-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3147/9968373/c8ab9f4bd237/Cell-J-25-92-g04.jpg

相似文献

1
Hsp70, in Combination with IL-15 and PD-1 Blocker, Interferes with The Induction of Cytotoxic NK Cells in Relapsed Acute Myeloid Leukemia Patients.热休克蛋白70(Hsp70)联合白细胞介素-15(IL-15)和程序性死亡受体1(PD-1)阻断剂可干扰复发急性髓系白血病患者中细胞毒性自然杀伤细胞的诱导。
Cell J. 2023 Feb 1;25(2):92-101. doi: 10.22074/cellj.2023.561054.1123.
2
Hsp70-Activated NK Cells in Combination With PD-1 Inhibition Significantly Increase Overall Survival in Preclinical Models of Glioblastoma and Lung Cancer.热休克蛋白 70 激活的自然杀伤细胞与 PD-1 抑制联合应用显著提高胶质母细胞瘤和肺癌的临床前模型的总生存率。
Front Immunol. 2019 Mar 22;10:454. doi: 10.3389/fimmu.2019.00454. eCollection 2019.
3
[Effect of PD-L1 Expression on Activity of NK Killing AML Cell Lines and Its Mechanisms].[程序性死亡配体1(PD-L1)表达对自然杀伤细胞杀伤急性髓系白血病细胞系活性的影响及其机制]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Oct;26(5):1317-1322. doi: 10.7534/j.issn.1009-2137.2018.05.010.
4
Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.白细胞介素-15/白细胞介素-15受体α信使核糖核酸工程化人树突状细胞对白细胞介素-15的转递呈递增强了抗肿瘤自然杀伤细胞活性。
Oncotarget. 2015 Dec 29;6(42):44123-33. doi: 10.18632/oncotarget.6536.
5
Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome.白细胞介素-6 抑制自然杀伤细胞细胞毒性:对巨噬细胞活化综合征发病机制的影响。
Arthritis Rheumatol. 2015 Nov;67(11):3037-46. doi: 10.1002/art.39295.
6
Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-alpha and PMA/ionomycin.白细胞介素-2、干扰素-α和佛波酯/离子霉素激活后人类自然杀伤细胞相关基因表达的差异调节
Int J Oncol. 1998 May;12(5):1165-70. doi: 10.3892/ijo.12.5.1165.
7
Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood.与成人外周血单个核细胞相比,活化脐带血单个核细胞中白细胞介素-15减少及其在增强脐带血抗肿瘤免疫活性和细胞因子产生方面的作用。
Blood. 1997 Oct 15;90(8):3106-17.
8
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations.PD-L1 靶向高亲和力 NK(t-haNK)细胞可诱导直接抗肿瘤作用,并靶向抑制性 MDSC 群体。
J Immunother Cancer. 2020 May;8(1). doi: 10.1136/jitc-2019-000450.
9
Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.急性髓系白血病中自然杀伤细胞上CD158和NKG2A抑制性受体的过表达以及NKG2D和NKp46激活受体的低表达
Arch Med Res. 2016 Jan;47(1):55-64. doi: 10.1016/j.arcmed.2016.02.001. Epub 2016 Feb 12.
10
Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.树突状细胞增强人脐带血CD34+细胞来源的自然杀伤细胞的细胞毒性
J Immunol. 2001 Feb 1;166(3):1590-600. doi: 10.4049/jimmunol.166.3.1590.

引用本文的文献

1
Natural Killer Cell Immune Checkpoints and Their Therapeutic Targeting in Cancer Treatment.自然杀伤细胞免疫检查点及其在癌症治疗中的靶向治疗
Research (Wash D C). 2025 Jun 3;8:0723. doi: 10.34133/research.0723. eCollection 2025.
2
Understanding the Mode of Action of Several Active Ingredients from the Micro-Immunotherapy Medicine 2LZONA.了解微免疫疗法药物2LZONA中几种活性成分的作用方式。
J Inflamm Res. 2025 Mar 21;18:4267-4290. doi: 10.2147/JIR.S498930. eCollection 2025.
3
The Functional Role and Prognostic Significance of TIM-3 Expression on NK Cells in the Diagnostic Bone Marrows in Acute Myeloid Leukemia.

本文引用的文献

1
Harnessing natural killer cells for the treatment of multiple myeloma.利用自然杀伤细胞治疗多发性骨髓瘤。
Semin Oncol. 2022 Feb;49(1):69-85. doi: 10.1053/j.seminoncol.2022.01.004. Epub 2022 Jan 21.
2
Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3.通过药物激活 FOXO3 促进 NK 和 CD8+T 细胞来使肿瘤对抗 PD-1 治疗敏感。
J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-002772.
3
Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives (Review).
TIM-3在急性髓系白血病诊断性骨髓中自然杀伤细胞上的表达的功能作用及预后意义
Biomedicines. 2024 Nov 27;12(12):2717. doi: 10.3390/biomedicines12122717.
4
Research Hotspots and Trends of NK Cell Immunotherapy for Acute Myeloid Leukemia: A Bibliometric Analysis From 2000 to 2023.急性髓系白血病自然杀伤细胞免疫治疗的研究热点与趋势:2000年至2023年的文献计量分析
Cancer Control. 2024 Jan-Dec;31:10732748241310937. doi: 10.1177/10732748241310937.
5
CTLA-4 Blockade of Natural Killer Cells Increases Cytotoxicity against Acute Lymphoid Leukaemia Cells Neda.自然杀伤细胞的CTLA-4阻断增强对急性淋巴细胞白血病细胞内达的细胞毒性
Cell J. 2024 Feb 1;26(2):150-157. doi: 10.22074/cellj.2024.2015187.1444.
6
Biomarkers in Adult-Type Diffuse Gliomas: Elevated Levels of Circulating Vesicular Heat Shock Protein 70 Serve as a Biomarker in Grade 4 Glioblastoma and Increase NK Cell Frequencies in Grade 3 Glioma.成人型弥漫性胶质瘤中的生物标志物:循环囊泡热休克蛋白70水平升高作为胶质母细胞瘤4级的生物标志物,并增加3级胶质瘤中的自然杀伤细胞频率。
Biomedicines. 2023 Dec 7;11(12):3235. doi: 10.3390/biomedicines11123235.
7
Progress of research on PD-1/PD-L1 in leukemia.PD-1/PD-L1 在白血病中研究进展。
Front Immunol. 2023 Sep 26;14:1265299. doi: 10.3389/fimmu.2023.1265299. eCollection 2023.
8
Exosomal PIK3CB promotes PD-L1 expression and malignant transformation in esophageal squamous cell carcinoma.外泌体 PIK3CB 促进食管鳞状细胞癌中 PD-L1 的表达和恶性转化。
Med Oncol. 2023 Jul 4;40(8):221. doi: 10.1007/s12032-023-02093-8.
基于自然杀伤细胞的肺癌免疫治疗:挑战与展望(综述)。
Oncol Rep. 2021 Nov;46(5). doi: 10.3892/or.2021.8183. Epub 2021 Sep 9.
4
Decrease post-transplant relapse using donor-derived expanded NK-cells.使用供体来源扩增的 NK 细胞减少移植后复发。
Leukemia. 2022 Jan;36(1):155-164. doi: 10.1038/s41375-021-01349-4. Epub 2021 Jul 26.
5
Inhibitors of immune checkpoints-PD-1, PD-L1, CTLA-4-new opportunities for cancer patients and a new challenge for internists and general practitioners.免疫检查点抑制剂-PD-1、PD-L1、CTLA-4-为癌症患者带来新机遇,也为内科医生和全科医生带来新挑战。
Cancer Metastasis Rev. 2021 Sep;40(3):949-982. doi: 10.1007/s10555-021-09976-0. Epub 2021 Jul 8.
6
Potential Role of Hsp70 and Activated NK Cells for Prediction of Prognosis in Glioblastoma Patients.热休克蛋白70(Hsp70)和活化自然杀伤细胞在胶质母细胞瘤患者预后预测中的潜在作用
Front Mol Biosci. 2021 May 17;8:669366. doi: 10.3389/fmolb.2021.669366. eCollection 2021.
7
PD-L1/PD-1 Axis in Multiple Myeloma Microenvironment and a Possible Link with CD38-Mediated Immune-Suppression.多发性骨髓瘤微环境中的PD-L1/PD-1轴及其与CD38介导的免疫抑制的可能联系
Cancers (Basel). 2021 Jan 6;13(2):164. doi: 10.3390/cancers13020164.
8
Natural killer cell-based immunotherapy for acute myeloid leukemia.基于自然杀伤细胞的免疫疗法治疗急性髓系白血病。
J Hematol Oncol. 2020 Dec 7;13(1):167. doi: 10.1186/s13045-020-00996-x.
9
Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDS.在急性髓系白血病/骨髓增生异常综合征造血干细胞移植中,氟达拉滨与白消安固定剂量减低强度预处理与基于药代动力学(PK)指导的白消安曲线下面积(FluBu4K)的比较。
Leuk Lymphoma. 2021 Apr;62(4):944-951. doi: 10.1080/10428194.2020.1849677. Epub 2020 Nov 24.
10
Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance.扩增和激活的同种异体自然杀伤细胞对 B 慢性淋巴细胞白血病 (B-CLL) 细胞具有细胞毒性,但也有少数耐药病例。
Sci Rep. 2020 Nov 10;10(1):19398. doi: 10.1038/s41598-020-76051-z.